Karyopharm Therapeutics Inc. buy Robert W. Baird
Start price
09.10.25
/
50%
€0.54
Target price
09.10.26
€18.04
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 09.10.26. The prediction end date can be changed by Robert_W__Baird at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karyopharm Therapeutics Inc. | - | - |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by Robert_W__Baird for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics (NASDAQ:KPTI) had its price target lowered by analysts at Robert W. Baird from $25.00 to $21.00. They now have an "outperform" rating on the stock.
Ratings data for KPTI provided by MarketBeat
Stopped prediction by Robert_W__Baird for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
12.08.25
12.08.25
€21.52
12.08.26
12.08.26
-
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
13.05.25
13.05.25
€37.81
13.05.26
13.05.26
-
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
03.03.25
03.03.25
€51.55
03.03.26
03.03.26
-
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.72
07.08.24
07.08.24
€4.57
07.08.25
07.08.25
-25.10%
08.08.25
08.08.25

